Alzheimer Risk Reduced by 43%: The Surprising Benefits of SGLT2 Inhibitors
Recent studies reveal an intriguing side effect of SGLT2 inhibitors and GLP-1 agonists: they significantly reduce the risk of Alzheimer’s disease among diabetics. According to data from the National Institutes…
